AfricaTopSuccess They make Africa
Vaccine deliveries to Europe by Pfizer bioN tech will be reduced “as of next week” while the company increases its production capacity, Norwegian health officials have said.
“The temporary reduction will affect all European countries,” Norway’s Public Health Agency (FHI) said in a statement.
“It is not immediately clear how long it will take for Pfizer to attain maximum production capacity, which will rise from 1.3 to 2 billion doses annually.”
The FHI gave no data on deliveries to Europe as a whole, but said Norway would next week get 36,075 doses, down from the 43,875 previously expected.
Pfizer initially said deliveries were proceeding according to the schedule agreed.
Read more: The various variant of Sars-Cov-2, responsible for Covid-19
But it later confirmed there would be an impact on distribution in late January to early February due to changes to manufacturing processes to boost production.
The institute said there would be no delays in the rollout of the vaccines to Norwegians as it stocked reserves.
Meanwhile, the first Moderna vaccine was given in Norway on Friday.
